IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
news byte: long-acting injected Olanzapine
From:
Sylvia Caras <[log in to unmask]>
Reply To:
[log in to unmask]
Date:
Mon, 8 Sep 2008 11:30:32 -0700
Content-Type:
text/plain
Parts/Attachments:
text/plain (13 lines) 
Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment 
Benefit in Schizophrenia for up to Six Months

BARCELONA, Spain, Sept. 2 /PRNewswire-FirstCall/ -- Final results from a 
24-week study presented today at a major medical meeting in Barcelona 
suggest that investigational olanzapine long-acting injection (LAI) 
therapeutic doses showed a maintenance of treatment benefit for up to 
six months.



Powered by LSoft's LISTSERV(R) list management software

ATOM RSS1 RSS2